Company / SG&A Expense
Health Catalyst, Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$76.6M
FY2025
5-year range
$31.7M / $85.9M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $86M to $77M over the past 2 years.
Based on SEC 10-K filings.
$77M in FY2025 with a 5-year CAGR of +27.5%.
Improved from $86M to $77M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +27.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +27.5%, indicating consistent growth.
- In FY2025, sg&a expense increased 24.1% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $76.6M | +24.1% |
| FY2024 | $61.7M | -28.2% |
| FY2023 | $85.9M | +45.1% |
| FY2022 | $59.2M | +86.8% |
| FY2021 | $31.7M | +39.8% |
| FY2020 | $22.7M | +54.4% |
| FY2019 | $14.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026